Evidence-based screening guidance in clinical preventive medicine establishes that, for asymptomatic average-risk adults, regular colorectal cancer screening between defined age bounds reduces cancer mortality regardless of which validated test modality is used, with the choice among modalities (fecal immunochemical/occult blood testing, colonoscopy, or flexible sigmoidoscopy plus fecal testing) determined by test-specific screening intervals and shared decision-making between patient and clinician rather than by superiority of one test over another. This exemplifies the broader principle in preventive medicine that screening recommendations are risk-stratified, applying only to defined average-risk populations and excluded when personal or family history elevates baseline risk.
Evidence-based screening guidance in clinical preventive medicine establishes that, for asymptomatic average-risk adults, regular colorectal cancer screening between defined age bounds reduces cancer…